Envafolimab

DB15769InvestigationalProtein Based Therapies

Envafolimab: Overview.

Mechanism: Pharmacologically active on Programmed cell death 1 ligand 1
Curator reviewed
Also known as: Envolizumab
Code names: KN-035

Resolves to

Compound

Targets

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

95Clinical trialsPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with Envafolimab, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.